Our technologies have potential efficacy and usefulness in a wide range of applications. We are currently looking for owners of complementary technologies for joint research or affiliates interested in clinical exploration of additional indications for our own technologies.
Expansion Technology:
Proteonomix is developing a unique growth medium that allows expansion far beyond the traditional 10:1 achieved in conventional methods before cellular replication errors make it nonviable. This technology is of benefit to any treatment or process that might be improved by drastically increased concentrations or numbers of cells.
Cryopreservation:
Proteonomix is developing an innovative cryopreservation technique resulting in substantial reduction in lost cells during the freezing and thawing process. This technology is of benefit where it is advantageous to store cellular material for later use, to maintain stock, or to perform long distance transportation.
Anti-Inflammatory:
Proteonomix's StromaCel™ cellular materials has given some indications as a general anti-inflammatory. We are looking for partners wishing to explore this indication for conditions other than myocardial infarction.
Expansion Technology:
